Globus Medical (GMED) Files $100M IPO
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Join SI Premium – FREE
Globus Medical, Inc. (NYSE: GMED), filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $100 million. Globus plans to list on the New York Stock Exchange under the ticker, "GMED."
The offering is being made through BofA Merrill Lynch, Goldman, Sachs & Co., Piper Jaffray, Leerink Swann, Canaccord Genuity, William Blair & Company, and Oppenheimer & Co.
Globus Medical a medical device company focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders.
The offering is being made through BofA Merrill Lynch, Goldman, Sachs & Co., Piper Jaffray, Leerink Swann, Canaccord Genuity, William Blair & Company, and Oppenheimer & Co.
Globus Medical a medical device company focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lyntris files for IPO, plans to list on NYSE under "LYNX"
- SK Group and Nvidia announce $500B+ AI infrastructure partnership
- China SXT Pharmaceuticals closes $9M registered direct offering
Create E-mail Alert Related Categories
IPOsRelated Entities
Piper Jaffray, William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
